Hedner U - Search Results

1

Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates.

Sundell IB, Marzec UM, Kelly AB, Chronos NA, Petersen LC, Hanson SR, Hedner U, Harker LA. Sundell IB, et al. Among authors: hedner u. Circulation. 1997 Aug 5;96(3):941-8. doi: 10.1161/01.cir.96.3.941. Circulation. 1997. PMID: 9264505

2

The effect of recombinant aprotinin on t-PA-induced bleeding in rats.

Erhardtsen E, Bregengaard C, Hedner U, Diness V, Halkjaer E, Petersen LC. Erhardtsen E, et al. Among authors: hedner u. Blood Coagul Fibrinolysis. 1994 Oct;5(5):707-12. doi: 10.1097/00001721-199410000-00005. Blood Coagul Fibrinolysis. 1994. PMID: 7532446

3

Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.

Petersen LC, Valentin S, Hedner U. Petersen LC, et al. Among authors: hedner u. Thromb Res. 1995 Jul 1;79(1):1-47. doi: 10.1016/0049-3848(95)00069-4. Thromb Res. 1995. PMID: 7495097 Review. No abstract available.

4

Generation of Gla-domainless FVIIa by cathepsin G-mediated cleavage.

Nicolaisen EM, Petersen LC, Thim L, Jacobsen JK, Christensen M, Hedner U. Nicolaisen EM, et al. Among authors: hedner u. FEBS Lett. 1992 Jul 20;306(2-3):157-60. doi: 10.1016/0014-5793(92)80989-t. FEBS Lett. 1992. PMID: 1633870 Free article.

5

Recombinant lys-plasminogen, but not glu-plasminogen, improves recombinant tissue-type plasminogen activator-induced coronary thrombolysis in dogs.

Mehta JL, Chen L, Nichols WW, Johannesen M, Bregengård C, Hedner U, Saldeen TG. Mehta JL, et al. Among authors: hedner u. J Am Coll Cardiol. 1995 Mar 1;25(3):753-60. doi: 10.1016/0735-1097(94)00444-u. J Am Coll Cardiol. 1995. PMID: 7860925 Free article.

6

Potentiated thrombolysis in a Chandler system using rtPA and lys-plasminogen.

Ljungberg J, Hedner U. Ljungberg J, et al. Among authors: hedner u. Thromb Res. 1989 Mar 15;53(6):569-76. doi: 10.1016/0049-3848(89)90146-1. Thromb Res. 1989. PMID: 2499945

7

Antithrombotic properties of a truncated recombinant tissue factor pathway inhibitor in an experimental venous thrombosis model.

Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JL, Nielsen G, Hedner U. Holst J, et al. Among authors: hedner u. Haemostasis. 1993 Mar;23 Suppl 1:112-7. doi: 10.1159/000216920. Haemostasis. 1993. PMID: 8495862

8

Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin.

Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JG, Nielsen G, Hedner U. Holst J, et al. Among authors: hedner u. Thromb Haemost. 1994 Feb;71(2):214-9. Thromb Haemost. 1994. PMID: 8191401

9

Potential role for rFVIIa in transfusion medicine.

Hedner U, Erhardtsen E. Hedner U, et al. Transfusion. 2002 Jan;42(1):114-24. doi: 10.1046/j.1537-2995.2002.00017.x. Transfusion. 2002. PMID: 11896322 Review. No abstract available.

10

Potential role of recombinant factor VIIa as a hemostatic agent.

Hedner U, Erhardtsen E. Hedner U, et al. Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9. Clin Adv Hematol Oncol. 2003. PMID: 16224390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters